The following Test Facilities have been inspected by the Swiss Monitoring Authorities. It was found that they were operating in compliance with the GLP Principles at the time they were inspected. The Facilities are in the compliance monitoring programme of the authorities.
According to article 6 paragraph 2 of the Ordinance on Good Laboratory Practice (OGLP), the Test Facilites are re-inspected every two to three years on a routine basis.
The list is regularly updated according to article 14 OGLP. In case of doubt concerning the actual situation of a particular Facility please contact the notification authority for chemicals.
| Test Facilities | Last Inspect. |
Areas of Expertise* |
|---|---|---|
| AnaPath GmbH 4625 Oberbuchsiten AnaPath Services 4410 Liestal |
Sep 2017 | OTH (histopathology) |
| AO Research Institute Davos 7270 Davos Platz |
Nov 2015 | TOX |
| Arcadis Schweiz AG 8952 Schlieren |
Mar 2017 | ECT, ENF, PCT |
| Bracco Suisse SA 1228 Plan-les-Ouates, Geneva |
Mar 2016 | ACC, TOX |
| b Sys GmbH 4108 Witterswil |
Mar 2015 | OTH (Electrophysiology) |
| Celerion Switzerland AG 8320 Fehraltorf |
Nov 2015 | ACC |
| F.Hoffmann-La Roche Ltd. Pharma Research 4070 Basel |
Feb 2017 | ACC, MUT, OTH (pharmacokinetics, safety pharmacology, pathology evaluation) |
| Firmenich SA Laboratoire de biodégradation 1211 Genève |
Mar 2016 | OTH (biodegradation) |
| Givaudan SA Ecotoxicology 1214 Vernier |
Mar 2016 | ENF, PCT |
| Idorsia Ltd. 4123 Allschwil |
Nov 2015 | ACC |
| Innovative Environmental Services (IES) Ltd. 4108 Witterswil |
Aug 2017 | PCT, ECT, ENF, RES, ACC, OTH (in vitro metabolism/dermal penetration) |
| Institute for Biopharmaceutical Research (IBR), Inc. 9548 Matzingen |
Nov 2016 | ACC, OTH (pharmacokinetics, immunological testing) |
| Intertek (Schweiz) AG TechCenter Reinach 4153 Reinach |
Dec 2016 | PCT, ACC |
| LKC Switzerland Ltd 4414 Füllinsdorf |
May 2015 | OTH (study direction of multisite residue studies) |
| Max Zeller Söhne AG Zeller Preclinical Research 8590 Romanshorn |
Sep 2015 | OTH (cytotoxicity, interactions) |
| MSRU Vetsuisse Faculty Zürich 8057 Zürich |
Feb 2017 | OTH (biocompability and efficacy with medical devices and pharmaceuticals) |
| Novartis Pharma AG PCS/ Project Pathology 4002 Basel |
Sep 2016 | OTH (pathology review) |
| Philip Morris Products S.A. Research and Development PMI Product Testing 2000 Neuchâtel |
Sep 2015 | PCT, MUT, ACC, OTH (in vitro toxicity) |
| SGS M-Scan SA 1228 Plan-les-Ouates |
Nov 2016 | ACC |
| Swiss BioQuant AG 4153 Reinach |
Sep 2016 | ACC |
| Syngenta Crop Protection AG GLP Testing Facility WMU 4333 Münchwilen |
Apr 2017 | ACC, PCT |
| SYNLAB pharma institute AG 4127 Birsfelden |
May 2017 | ACC, OTH (in vitro cytotoxicity) |
Areas of Expertise:
PCT Physical-chemical testing
TOX Toxicity studies
MUT Mutagenicity studies
ECT Environmental toxicity studies on aquatic and terrestrial organisms
ENF Studies on behaviour in water, soil, and air; bioaccumulation
RES Residue studies
EMN Studies on effects on mesocosms and natural ecosystems
ACC Analytical and clinical chemistry testing
OTH Other studies, specify
Last modification 26.09.2016
